RENGA, GIORGIA
 Distribuzione geografica
Continente #
NA - Nord America 2.107
AS - Asia 1.649
EU - Europa 1.420
SA - Sud America 238
AF - Africa 42
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.460
Nazione #
US - Stati Uniti d'America 2.052
SG - Singapore 829
IT - Italia 454
CN - Cina 241
IE - Irlanda 233
HK - Hong Kong 205
BR - Brasile 192
RU - Federazione Russa 171
VN - Vietnam 119
DE - Germania 112
FR - Francia 84
SE - Svezia 69
GB - Regno Unito 65
IN - India 48
FI - Finlandia 47
RO - Romania 34
BD - Bangladesh 31
AT - Austria 28
KR - Corea 28
CA - Canada 27
TR - Turchia 26
JP - Giappone 25
UA - Ucraina 24
BE - Belgio 20
NL - Olanda 20
MX - Messico 19
PK - Pakistan 19
PL - Polonia 15
IQ - Iraq 14
ZA - Sudafrica 14
AR - Argentina 13
ES - Italia 9
MA - Marocco 9
SA - Arabia Saudita 9
CO - Colombia 8
EC - Ecuador 8
ID - Indonesia 8
UZ - Uzbekistan 8
CH - Svizzera 7
LT - Lituania 7
PH - Filippine 7
CZ - Repubblica Ceca 6
JO - Giordania 6
CL - Cile 5
GR - Grecia 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
IL - Israele 4
CI - Costa d'Avorio 3
ET - Etiopia 3
LB - Libano 3
NI - Nicaragua 3
PA - Panama 3
AO - Angola 2
AU - Australia 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BO - Bolivia 2
CR - Costa Rica 2
DZ - Algeria 2
EG - Egitto 2
HR - Croazia 2
KG - Kirghizistan 2
LK - Sri Lanka 2
MU - Mauritius 2
MY - Malesia 2
PE - Perù 2
PT - Portogallo 2
SI - Slovenia 2
TN - Tunisia 2
DM - Dominica 1
EU - Europa 1
GH - Ghana 1
GY - Guiana 1
HU - Ungheria 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PS - Palestinian Territory 1
PY - Paraguay 1
RS - Serbia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
UG - Uganda 1
UY - Uruguay 1
Totale 5.460
Città #
Singapore 645
Chandler 326
Dublin 229
Perugia 227
Hong Kong 203
San Jose 201
Ashburn 153
Ann Arbor 106
San Mateo 81
Santa Clara 80
Boardman 79
Moscow 60
Munich 60
Beijing 55
Altamura 53
Los Angeles 51
Lauterbourg 49
Medford 47
The Dalles 47
Princeton 46
New York 44
Lawrence 42
Andover 32
Dong Ket 32
Turku 30
Wilmington 29
Ho Chi Minh City 28
Seoul 25
Des Moines 24
Hanoi 24
Bucharest 22
Tokyo 22
Orem 21
Brussels 20
São Paulo 19
Vienna 19
Stockholm 16
Poplar 14
Bologna 13
Dearborn 13
Redmond 13
Vicenza 13
Warsaw 13
Falls Church 12
Atlanta 11
Brooklyn 11
Dallas 11
Nuremberg 11
Woodbridge 11
Belo Horizonte 10
Chennai 10
Johannesburg 10
Lahore 10
Norwalk 10
Piscataway 10
Shenzhen 10
Chicago 9
Guangzhou 9
Ankara 8
Frankfurt am Main 8
Lappeenranta 8
Phoenix 8
Rome 8
San Paolo di Civitate 8
Amsterdam 7
Camerino 7
Council Bluffs 7
Houston 7
Montreal 7
Saint Petersburg 7
Shanghai 7
Amman 6
Columbus 6
Denver 6
Haiphong 6
Hefei 6
Helsinki 6
Kocaeli 6
Manchester 6
Milan 6
Mumbai 6
Ottawa 6
Rio de Janeiro 6
Santarcangelo di Romagna 6
Verona 6
Barnet 5
Boston 5
Brno 5
Da Nang 5
Dhaka 5
Jeddah 5
London 5
Măgurele 5
New Delhi 5
Paris 5
Querétaro 5
Toronto 5
Turin 5
Cambridge 4
Charlotte 4
Totale 3.735
Nome #
Autophagy and LAP in the Fight against Fungal Infections: Regulation and Therapeutics 174
Antifungal Th Immunity: Growing up in Family 160
A mast cell-ILC2-Th9 pathway promotes lung inflammation in cystic fibrosis 159
Targeting RAGE prevents muscle wasting and prolongs survival in cancer cachexia 146
Aryl Hydrocarbon Receptor Agonism Antagonizes the Hypoxia-driven Inflammation in Cystic Fibrosis 143
IL-9 and Mast Cells Are Key Players of Candida albicans Commensalism and Pathogenesis in the Gut 143
Selectively targeting key inflammatory pathways in cystic fibrosis 139
Cellular proteostasis: a new twist in the action of thymosin α1 137
Microbes in the Era of Circadian Medicine 127
Definition of the Anti-inflammatory Oligosaccharides Derived From the Galactosaminogalactan (GAG) From Aspergillus fumigatus 123
CPX-351 exploits the gut microbiota to promote mucosal barrier function, colonization resistance, and immune homeostasis 122
Noncanonical Fungal Autophagy Inhibits Inflammation in Response to IFN-γ via DAPK1. 121
Genetic polymorphisms affecting IDO1 or IDO2 activity differently associate with aspergillosis in humans 118
Anakinra activates superoxide dismutase 2 to mitigate inflammasome activity 118
A pathogenic role for cystic fibrosis transmembrane conductance regulator in celiac disease 117
A High-Risk Profile for Invasive Fungal Infections Is Associated with Altered Nasal Microbiota and Niche Determinants 116
Circadian Regulation of Xenobiotic Metabolism during Anticancer Treatment 115
Anakinra restores cellular proteostasis by coupling mitochondrial redox balance to autophagy 115
Optimizing therapeutic outcomes of immune checkpoint blockade by a microbial tryptophan metabolite 113
Targeted Drug Delivery Technologies Potentiate the Overall Therapeutic Efficacy of an Indole Derivative in a Mouse Cystic Fibrosis Setting 111
Towards Targeting the Aryl Hydrocarbon Receptor in Cystic Fibrosis 108
Indole-3-Carboxaldehyde Restores Gut Mucosal Integrity and Protects from Liver Fibrosis in Murine Sclerosing Cholangitis 108
A shifted composition of the lung microbiota conditions the antifungal response of immunodeficient mice 107
Thymosin α1 protects from CTLA-4 intestinal immunopathology 104
Tryptophan Co-Metabolism at the Host-Pathogen Interface 103
Development and in vitro-in vivo performances of an inhalable indole-3-carboxaldehyde dry powder to target pulmonary inflammation and infection 101
A Reappraisal of Thymosin Alpha1 in Cancer Therapy 100
THE MICROBIAL LANDSCAPE OF HEMATOLOGICAL PATIENTS AT RISK FOR ASPERGILLOSIS 100
Bridging of host-microbiota tryptophan partitioning by the serotonin pathway in fungal pneumonia 96
Fungal chitin induces trained immunity in human monocytes during cross-talk of the host with Saccharomyces cerevisiae 96
Thymosin alpha1 mitigates intestinal immunopathology on immune checkpoint inhibition 96
Pharyngeal microbial signatures are predictive of the risk of fungal pneumonia in hematologic patients 96
Tryptophan as a Central Hub for Host/Microbial Symbiosis 94
A microbially produced AhR ligand promotes a Tph1-driven tolerogenic program in multiple sclerosis 93
Reply to ‘F508del-CFTR is not corrected by thymosin α1’ 93
Thymosin alpha 1 exerts beneficial extrapulmonary effects in cystic fibrosis 93
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 93
The circadian control of tryptophan metabolism regulates the host response to pulmonary fungal infections 91
IL-37 inhibits inflammasome activation and disease severity in murine aspergillosis 89
Pyridoxal 5′-phosphate-dependent enzymes at the crossroads of host–microbe tryptophan metabolism 87
The Mast Cell-Aryl Hydrocarbon Receptor Interplay at the Host-Microbe Interface 86
Mast cells respond to candida albicansinfections and modulate macrophages phagocytosis of the fungus 85
Thymosin β4 promotes autophagy and repair via HIF-1α stabilization in chronic granulomatous disease 85
To Be or Not to Be a Pathogen: Candida albicans and Celiac Disease 83
Thymosin alpha 1 in cystic fibrosis: from the lung to the gut 83
IL-9 Integrates the Host-Candida Cross-Talk in Vulvovaginal Candidiasis to Balance Inflammation and Tolerance 82
Targeting the Aryl Hydrocarbon Receptor With Indole-3-Aldehyde Protects From Vulvovaginal Candidiasis via the IL-22-IL-18 Cross-Talk 82
CAR T cells targeting Aspergillus fumigatus are effective at treating invasive pulmonary aspergillosis in preclinical models 73
COVID-19 and beyond: Reassessing the role of thymosin alpha1 in lung infections 72
Thymosin β4 limits inflammation through autophagy 69
The microbiota/host immune system interaction in the nose to protect from COVID-19 66
Rapidly expanded partially HLA DRB1-matched fungus-specific T cells mediate in vitro and in vivo antifungal activity 66
Small molecule ccr4 antagonists protect mice from aspergillus infection and allergy 60
The immune and microbial homeostasis determines the Candida–mast cells cross-talk in celiac disease 52
SARS-CoV-2 Infection is Associated with Age- and Gender-Specific Changes in the Nasopharyngeal Microbiome 50
Totale 5.659
Categoria #
all - tutte 23.589
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.589


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202175 0 0 0 0 0 0 0 0 0 21 18 36
2021/2022469 13 78 10 27 25 8 19 100 15 28 70 76
2022/2023974 53 182 13 103 111 101 6 43 317 6 30 9
2023/2024430 30 55 20 16 9 4 104 3 20 22 67 80
2024/20251.177 18 69 23 75 114 76 133 141 203 58 157 110
2025/20262.145 143 106 99 271 373 216 403 137 231 166 0 0
Totale 5.659